Theravance Inc. (THRX): Today's Featured Drugs Laggard
(
) pushed the Drugs industry lower today making it today's featured Drugs laggard. The industry as a whole closed the day up 1.0%. By the end of trading, Theravance fell $0.55 (-1.3%) to $42.09 on light volume. Throughout the day, 1,162,778 shares of Theravance exchanged hands as compared to its average daily volume of 1,875,100 shares. The stock ranged in price between $41.00-$42.96 after having opened the day at $42.78 as compared to the previous trading day's close of $42.64. Other companies within the Drugs industry that declined today were:
(
), down 34.6%,
(
), down 12.3%,
(
), down 7.8% and
(
), down 7.7%.
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. Theravance has a market cap of $4.1 billion and is part of the health care sector. Shares are up 84.1% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Theravance a buy, no analysts rate it a sell, and 2 rate it a hold.
TheStreet Ratings rates
Theravance
as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk and feeble growth in its earnings per share.
- You can view the full Theravance Ratings Report.
On the positive front,
(
), up 19.5%,
(
), up 15.9%,
(
), up 15.3% and
(
), up 15.0% , were all gainers within the drugs industry with
Teva Pharmaceutical Industries
(
) being today's featured drugs industry leader.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null